GHO Capital Acquires Genesis Research
November 16, 2021
London-based GHO Capital Partners has acquired Genesis Research, a Hoboken, New Jersey–headquartered provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The transaction, which follows a prior recapitalization by Rallyday Partners, gives Genesis additional capital and European market expertise to pursue global expansion and adjacent capability growth.
- Buyers
- GHO Capital Partners LLP
- Targets
- Genesis Research
- Sellers
- Rallyday Partners, Founders of Genesis Research
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Rallyday Partners Invests in Genesis Research
March 4, 2020
Healthcare Services
Rallyday Partners, a Denver-based private equity firm, has made a growth investment in Genesis Research LLC, a Hoboken, New Jersey-headquartered provider of real-world evidence (RWE) and HEOR services for the life sciences industry. The investment will support Genesis Research's expansion of services, capabilities, and geographic reach and enable continued organic growth and M&A activity.
-
Genesis Research Acquires Market Access Transformation
May 16, 2022
Healthcare Services
Genesis Research, a GHO-backed provider of tech-enabled Real-World Evidence (RWE) and HEOR services, has acquired Market Access Transformation (MAT), a developer of payer research technology platforms. The acquisition expands Genesis's market-access and subscription/technology capabilities, increasing Genesis' headcount from 145 to 215 and marking the exit of investor Silversmith Capital Partners from MAT.
-
Athagoras Acquires Quantify Research
January 8, 2025
Healthcare Services
Athagoras, a Munich-based life sciences consulting platform, has acquired Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE), health economics (HEOR) and market access. The acquisition expands Athagoras' RWE and market access capabilities and strengthens its presence in the Nordic region and Asia-Pacific to better serve global pharmaceutical clients.
-
GHO Capital Acquires Velocity Clinical Research
July 15, 2021
Healthcare Services
Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.
-
New Residential Investment Corp. Acquires Genesis Capital LLC
December 20, 2021
Financial Services
New Residential Investment Corp. completed its acquisition of Genesis Capital LLC, a Sherman Oaks-based business-purpose lender, from affiliates of Goldman Sachs. The deal, financed with New Residential cash and committed asset-based financing from Goldman Sachs, adds loan origination capability to New Residential's single-family rental platform; Genesis originated roughly $2 billion of loans in 2021 and has about 170 employees.
-
GHO Capital and Partners Group Invest in Sterling Pharma Solutions
May 25, 2023
Pharmaceuticals
GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.